Sign in
CompletedPhase 3

A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age

Key facts

Who runs it
ModernaTX, Inc.
Where
Albuquerque, Anderson, Annapolis, Anniston, Atlanta, Austin, Baton Rouge, Beaumont, Berlin, Birmingham, Bountiful, Brookline, Brooklyn, Brownsville, Cerritos, Charlotte, Chicago, Cincinnati, Columbus, Corvallis, Covington, Creve Coeur, Cullman, Dallas, Decatur, Doral, Edmond, El Paso, Elkhorn, Evansville, Fayetteville, Fort Collins, Fort Worth, Fremont, Friendswood, Gulfport, Hatboro, Henderson, Hendersonville, Hialeah, Hollywood, Houston, Huber Heights, Humble, Inverness, Jacksonville, Jupiter, Kansas City, Largo, Las Vegas, Leesburg, Lenexa, Lincoln, Long Beach, Longmont, Los Alamitos, Louisville, Maitland, Mandeville, Mankato, McKinney, Melbourne, Mesa, Miami, Modesto, Monroe, Morton, Myrtle Beach, New Orleans, New York, Norcross, North Hollywood, North Las Vegas, Oklahoma City, Omaha, Overland Park, Papillion, Peoria, Philadelphia, Phoenix, Pleasant View, Pomona, Portsmouth, Prairieville, Richfield, River Forest, Riverside, Rochester, Rockville, Rolling Hills Estates, Roy, Saint Augustine, Salt Lake City, San Angelo, San Antonio, San Diego, San Marcos, Santa Fe, Savannah, Scottsdale, Silver Spring, South Salt Lake, Southfield, Spartanburg, Springfield, St Louis, Stamford, Stephenville, Stockbridge, Sugar Land, Tampa, Tempe, Tomball, Town and Country, Tulsa, Valparaiso, Versailles, Vista, Waterbury, Wenatchee, West Des Moines, Wichita, Wilmington, and Yukon, United StatesSee the 145 sites
Trial code
Status
Completed
Phase
Phase 3
People taking part
8,061 people enrolled
Started
19 Oct 2023
Ended
28 May 2024
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • mRNA-1083
  • Placebo
  • Influenza Vaccine
  • COVID-19 Vaccine
Record updated
1 July 2025

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Healthy adults either ≥65 years of age (Cohort A) or 50 to <65 years of age (Cohort B) at the time of consent (Screening Visit)
  • For female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to Day 1, and agreement to continue adequate contraception through 3 months following vaccine administration
  • Fully vaccinated for COVID-19 primary series according to the locally authorized or approved regimen, and their last COVID-19 vaccine (primary series or booster) was ≥90 days prior to Day 1

Who cannot take part

  • Participant is acutely ill or febrile (temperature ≥38.0 degrees Celsius [°C]/100.4 degrees Fahrenheit [°F]) 72 hours prior to or at the Screening Visit or Day 1
  • Participant has received systemic immunosuppressants for >14 days in total within 180 days prior to Day 1 (for corticosteroids, ≥10 milligrams [mg]/day of prednisone or equivalent) or is anticipating the need for systemic immunosuppressive treatment at any time during participation in the study. Inhaled nasal and topical steroids are allowed
  • Received or plans to receive any vaccine authorized or approved by a local health agency ≤28 days prior to study injections or plans to receive a vaccine authorized or approved by a local health agency within 28 days after the study injections
  • Received a seasonal influenza vaccine ≤150 days prior to Day 1
  • Tested positive for influenza by local health authority-approved testing methods ≤150 days prior to Day 1
  • Has had close contact to someone with COVID-19 as defined by the Centers for Disease Control and Prevention (CDC) in the past 10 days prior to Day 1
  • Has donated ≥450 milliliters (mL) of blood products within 28 days prior to the Screening Visit or plans to donate blood products during the study; Note: Other protocol-defined inclusion/exclusion criteria may apply
  • Any medical, psychiatric, or occupational condition, including reported history of drug or alcohol abuse, that, in the opinion of the Investigator, might pose additional risk due to participation in the study or could interfere with the interpretation of study results

Where in United States

  • Velocity Clinical Research - Albuquerque - PPDSAlbuquerque, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - AndersonAnderson, United States
  • Annapolis Internal Medicine - CCT - PPDSAnnapolis, United States
  • Pinnacle Research Group-409 E 10th StAnniston, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - AtlantaAtlanta, United States
  • DelRicht Research, LLC - Springer Wellness & Restorative - Atlanta - PPDSAtlanta, United States
  • AES - DRS - Optimal Research Texas - AustinAustin, United States
  • Benchmark Research - Austin - HyperCore - PPDSAustin, United States
  • Tekton Research - Austin - PPDSAustin, United States
  • Velocity Clinical Research (Baton Rouge - Louisiana) - PPDSBaton Rouge, United States
  • Tekton Research Inc.Beaumont, United States
  • Hassman Research Institute - HRI - Berlin - CenExel - PPDSBerlin, United States
  • Accel Research Site - Achieve - BirminghamBirmingham, United States
  • Cope Family Medicine - CCT - PPDSBountiful, United States
  • DM Clinical Research - The Brook House - ERN - PPDSBrookline, United States
  • DM Clinical Research - BrooklynBrooklyn, United States
  • Headlands Research - Brownsville - Headlands - PPDSBrownsville, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - CerritosCerritos, United States
  • DelRicht Research, LLC - Charlotte - PPDSCharlotte, United States
  • Tryon Medical Partners, PLLC and Javara Inc. - Javara - PPDSCharlotte, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - ChicagoChicago, United States
  • Cedar Crosse Research CenterChicago, United States
  • Flourish Research - Andersonville - PPDSChicago, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - CincinnatiCincinnati, United States
  • CTI Clinical Research Center - PPDSCincinnati, United States
  • Velocity Clinical Research (Cincinnati - Ohio) - PPDSCincinnati, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - ColumbusColumbus, United States
  • The Corvallis Clinic, PC - 3680 NW Samaritan DriveCorvallis, United States
  • Velocity Clinical Research - Covington - PPDSCovington, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - St. LouisCreve Coeur, United States
  • Cullman Clinical TrialsCullman, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - DallasDallas, United States
  • iResearch Atlanta - CenExel - PPDSDecatur, United States
  • Revival Research CorporationDoral, United States
  • Tekton Research - Edmond - PPDSEdmond, United States
  • 3A Research, LLCEl Paso, United States
  • Skyline Medical Center - PC - CCT - PPDSElkhorn, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - EvansvilleEvansville, United States
  • Javara, Inc./Privia Medical Group Georgia, LLC - Fayetteville - Javara - PPDSFayetteville, United States
  • Tekton Research - Fort Collins - PPDSFort Collins, United States
  • Privia Medical Group- North Texas - West Parker Road - Fort Worth - Javara - PPDSFort Worth, United States
  • Methodist Physicians Clinic - CCT Research - PPDSFremont, United States
  • Mount Olympus Medical Research Group - ClinEdge - PPDSFriendswood, United States
  • DelRicht Research, LLC - Gulfport - PPDSGulfport, United States
  • Hatboro Medical Associates - CCT - PPDSHatboro, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - HendersonHenderson, United States
  • DelRicht Research, LLC - Hendersonville - PPDSHendersonville, United States
  • Indago Research and Health CenterHialeah, United States
  • CenExel RCA - HollywoodHollywood, United States
  • DM Clinical Research - Bellaire - ERN - PPDSHouston, United States
  • DM Clinical Research - Cyfair Clinical Research Center - ERN - PPDSHouston, United States
  • WellNow Urgent Care & Research - Huber HeightsHuber Heights, United States
  • DM Clinical Research - Texas Center for Drug Development - Humble - ERN - PPDSHumble, United States
  • Nature Coast Clinical ResearchInverness, United States
  • Jacksonville Center for Clinical ResearchJacksonville, United States
  • Health Awareness - Jupiter - ERN - ERNJupiter, United States
  • Clay Platte Family Medicine / CCT ResearchKansas City, United States
  • Accel Research Sites - Saint Petersburg - Largo - ERN - PPDSLargo, United States
  • Santa Rosa Urgent Care - Primary Care - CCT - PPDSLas Vegas, United States
  • Flourish Research - Leesburg - PPDSLeesburg, United States
  • Johnson County Clin-TrialsLenexa, United States
  • Velocity Clinical Research (Lincoln - Nebraska) - PPDSLincoln, United States
  • Long Beach Research Institute, LLCLong Beach, United States
  • Tekton Research - Longmont - PPDSLongmont, United States
  • CenExel Apex (CNS) - Los Alamitos - PPDSLos Alamitos, United States
  • DelRicht Research, LLC - Louisville - PPDSLouisville, United States
  • Accel Research Sites - MaitlandMaitland, United States
  • DelRicht Clinical Research, LLC - The Murphy Clinic - PPDSMandeville, United States
  • Mankato Clinic - Premier Drive - Javara - PPDSMankato, United States
  • DelRicht Research, LLC - Zomnir Family Medicine - DelRicht - PPDSMcKinney, United States
  • AES - DRS - Optimal Research Florida - MelbourneMelbourne, United States
  • Desert Clinical Research - CCT - PPDSMesa, United States
  • Suncoast Research Group LLC - Flourish - PPDSMiami, United States
  • Central Valley Research, LLCModesto, United States
  • IMA Clinical Research - Monroe, LA - PPDSMonroe, United States
  • Monroe Biomedical Research -343 Venus StMonroe, United States
  • Koch Family MedicineMorton, United States
  • TMA - Myrtle Beach - ERN - PPDSMyrtle Beach, United States
  • DelRicht Clinical Research, LLC - New Orleans - ClinEdge - PPDSNew Orleans, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - New YorkNew York, United States
  • Georgia Clinic - CCT - PPDSNorcross, United States
  • Carbon Health- NoHo West Urgent Care and Primary CareNorth Hollywood, United States
  • Las Vegas Clinical TrialsNorth Las Vegas, United States
  • Lynn Institute of East Oklahoma - ERN PPDSOklahoma City, United States
  • Midwest Regional Health Services - LLC - CCT - PPDSOmaha, United States
  • Velocity Clinical ResearchOmaha, United States
  • Delricht Overland ParkOverland Park, United States
  • Papillion Research CenterPapillion, United States
  • AES - DRS - Optimal Research Illinois - PeoriaPeoria, United States
  • DM Clinical Research - Philadelphia - ERN - PPDSPhiladelphia, United States
  • Foothills Research Center - CCT - PPDSPhoenix, United States
  • Ogden Clinic - Mountain View - CCT - PPDSPleasant View, United States
  • Empire Clinical ResearchPomona, United States
  • Velocity Clinical Research - Family Practice - Portsmouth - PPDSPortsmouth, United States
  • DelRicht Research, LLC - Internal - Baton Rouge - PPDSPrairieville, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - MinneapolisRichfield, United States
  • DM Clinical Research - Chicago - ERN - PPDSRiver Forest, United States
  • Artemis Institute For Clinical Research LLC - Riverside - Headlands - PPDSRiverside, United States
  • Clinical Innovations Trials - Riverside - CenExel - PPDSRiverside, United States
  • Rochester Clinical Research, IncRochester, United States
  • Advanced Primary Care & Geriatric Care - CCT - PPDSRockville, United States
  • DelRicht Clinical Research, LLC - Matthew Mintz, MD - PPDSRockville, United States
  • Velocity Clinical Research (Rockville - Maryland) - PPDSRockville, United States
  • Peninsula Research Associates - Headlands - PPDSRolling Hills Estates, United States
  • Ogden Clinic - Grandview - CCT - PPDSRoy, United States
  • St. Johns Center for Clinical Research - ERN - PPDSSaint Augustine, United States
  • JBR Clinical Research - CenExel JBR - PPDSSalt Lake City, United States
  • Benchmark Research - San Angelo - HyperCore - PPDSSan Angelo, United States
  • Clinical Trials of Texas, Inc. - PPDSSan Antonio, United States
  • IMA Clinical Research - San Antonio - PPDSSan Antonio, United States
  • Sun Research Institute -427 9th StSan Antonio, United States
  • Tekton Research - San Antonio - PPDSSan Antonio, United States
  • Artemis Institute For Clinical Research LLC - San Diego - Headlands - PPDSSan Diego, United States
  • Privia Medical Group Gulf Coast, PLLC - San Marcos - Javara - PPDSSan Marcos, United States
  • AXCES Research Group - Sante Fe - ERN - PPDSSanta Fe, United States
  • Privia Medical Group Georgia, LLC - Savannah - Javara - PPDSSavannah, United States
  • Headlands Research - Scottsdale - PPDSScottsdale, United States
  • Scottsdale Clinical TrialsScottsdale, United States
  • Privia Medical Group, LLC - Columbia Pike - Silver Spring - Javara - PPDSSilver Spring, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake CitySouth Salt Lake, United States
  • DM Clinical Research - Southfield - ERN - PPDSSouthfield, United States
  • Great Lakes Research InstituteSouthfield, United States
  • Headlands Research - Detroit - Headlands - PPDSSouthfield, United States
  • Velocity Clinical Research - Spartanburg - PPDSSpartanburg, United States
  • Clinvest - National Ave - Headlands - PPDSSpringfield, United States
  • DelRicht Research, LLC - Command Family Medicine - Springfield - DelRicht - PPDSSpringfield, United States
  • Sundance Clinical Research - ERN - PPDSSt Louis, United States
  • Stamford Therapeutics Consortium - ERN - PPDSStamford, United States
  • Privia Medical Group- North Texas - Stephenville - Javara - PPDSStephenville, United States
  • Clinical Research Atlanta - ERN - PPDSStockbridge, United States
  • DM Clinical Research - Sugarland - ERN - PPDSSugar Land, United States
  • ForCare Clinical Research - CenExel FCR - PPDSTampa, United States
  • Fiel Family & Sports Medicine - PC - CCT - PPDSTempe, United States
  • DM Clinical Research - ERN - PPDSTomball, United States
  • DelRicht Clinical Research, LLC - MS. Medicine - PPDSTown and Country, United States
  • DelRicht Research, LLC - Internal - Tulsa - PPDSTulsa, United States
  • Velocity Clinical Research - Valparaiso (Buynak Clinical Research) - PPDSValparaiso, United States
  • Versailles Family Medicine - CCT - PPDSVersailles, United States
  • AES - DRS - Synexus Clinical Research US, Inc. - VistaVista, United States
  • Chase Medical Research LLC - WaterburyWaterbury, United States
  • Wenatchee Valley Hospital & Clinics CampusWenatchee, United States
  • The Iowa Clinic, P.C. - West Des Moines CampusWest Des Moines, United States
  • Tekton Research - Wichita - PPDSWichita, United States
  • Trial Management Associates LLC - ERN - PPDSWilmington, United States
  • Tekton Research - Yukon - PPDSYukon, United States

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the immunogenicity, safety, and reactogenicity of mRNA-1083 as compared with active control, co-administered licensed influenza and severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) vaccines, in 2 independent age-group sub-study cohorts, healthy adults 65 years and older (Cohort A) and healthy adults 50 to <65 years of age (Cohort B).

The 4 groups in the trial

  • Cohort A1: mRNA-1083 and PlaceboTreatment being tested

    Participants of age 65 years and older will receive mRNA-1083 and placebo administered as 2 intramuscular (IM) injections of on Day 1.

    Treatment: mRNA-1083 and Placebo

  • Cohort A2: Influenza Vaccine and COVID-19 VaccineExisting treatment, for comparison

    Participants of age 65 years and older will receive age recommended quadrivalent influenza vaccine and COVID-19 vaccine administered as 2 IM injections on Day 1.

    Treatment: Influenza Vaccine and COVID-19 Vaccine

  • Cohort B1: mRNA-1083 and PlaceboTreatment being tested

    Participants of age 50 to \<65 years will receive mRNA-1083 and placebo administered as 2 IM injections of on Day 1.

    Treatment: mRNA-1083 and Placebo

  • Cohort B2: Influenza Vaccine and COVID-19 VaccineExisting treatment, for comparison

    Participants of age 50 to \<65 years will receive age recommended quadrivalent influenza vaccine and COVID-19 vaccine administered as 2 IM injections on Day 1.

    Treatment: Influenza Vaccine and COVID-19 Vaccine

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Phase 3, Randomized, Observer-Blind, Active-Control Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
Publications
Record updated
1 July 2025